Agilent
As on 18 Apr, 2026 | 01:29 IST
| Open | 118.25 |
| Previous Close | 118.25 |
| Beta | 0.42 |
| High | 121.92 |
| Low | 118.88 |
| TTM EPS See historical trend | 5.43(+15.57% YoY) |
| 52 Week High | 160.27 |
| 52 Week Low | 99.14 |
| TTM PE See historical trend | 22.44(Average PE) |
| Mkt. Cap ($ Billion) | 34.76 |
| Dividend Yield | 0.94 |
Advanced Chart
*Delayed by 20 seconds
MC Technicals
| Days | |
|---|---|
| 5 | 119.56 |
| 10 | 117.4 |
| 20 | 115.21 |
| 50 | 118.49 |
| 100 | 130.26 |
| 200 | 129.6 |
Returns
| 1 Week | 5.92% | |
| 1 Month | 8.09% | |
| 3 Months | -12.73% | |
| YTD | -10.44% | |
| 1 Year | 19.04% | |
| 3 Years | -13.07% |
Financialsin million $
Peers
| Name | Price ($) | Change% | M.Cap(Billion $) | TTM PE | TTM EPS | DY | 52 wk high/low | Technical Rating | |
|---|---|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | 526.60 | 2.05 | 200.73 | 23.02 | 22.87 | 0.30 | 643.99/385.72 | 11.36 | Very Bullish |
| Abbott | 96.81 | 1.40 | 167.96 | 18.80 | 5.15 | 1.92 | 139.02/93.95 | -12.53 | Very Bearish |
| Intuitive Surgical | 469.21 | 2.43 | 166.30 | 52.54 | 8.93 | -- | 603.70/427.84 | -2.80 | Very Bearish |
| Danaher | 194.77 | 0.51 | 140.68 | 24.97 | 7.80 | 0.56 | 242.75/180.09 | -0.05 | Neutral |
| Edwards Lifesciences | 80.94 | 2.39 | 47.77 | 31.64 | 2.56 | -- | 87.89/68.65 | -3.85 | Very Bullish |
Market news
- Wall St ends mixed, notches weekly gains as investors parse Middle East negotiationsApril 11, 2026 8:53 AM
- Wall Street skids as Middle East turmoil fans inflation fearMarch 21, 2026 9:02 AM
- Wall Street closes lower, posts weekly loss as war on Iran fuels inflation worriesMarch 14, 2026 8:59 AM
- US stocks close down as oil spikes 12%, job market weakensMarch 7, 2026 9:27 AM
About the company
Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. The Company’s business segments include life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. The life sciences and applied markets business segment provides application-focused solutions that include instruments and software. The Company's diagnostics and genomics business segment includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses. The Company's Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.